Atlas Trials

HER2-Negative Locally Advanced Breast Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HER2-Negative Locally Advanced Breast Cancer

RecordFirmDate
Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer (NCT01520103)AIO-Studien-gGmbH2012-01-01

Track HER2-Negative Locally Advanced Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.